Author details

Full Name

Ho-Shin Gwak

Affiliation

National Cancer Center

ORCID

Career Start Year

1994

Papers

102

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36762803	Molecular Biology of Brain Metastases.	Brain Tumor Res Treat	2023
37747775	Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.	Cancer Res	2023
38061763	Clinical Safety and Efficiency of the H-Port for Treatment of Leptomeningeal Metastasis.	J Korean Neurosurg Soc	2023
36503217	Leptomeningeal Metastasis in Gliomas : Clinical Characteristics and Risk Factors.	J Korean Neurosurg Soc	2023
35050202	Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases.	Metabolites	2022
35545833	Recurrent L3 Chordoma Presented as Intradural Extramedullary Mass With Distant Metastasis: A Case Report.	Brain Tumor Res Treat	2022
36311686	Cerebrospinal fluid neurofilament light chain as a potential prognostic biomarker for leptomeningeal metastasis.	Oncol Lett	2022
36347638	Lumboperitoneal Shunt Combined With Ommaya Reservoir Enables Continued Intraventricular Chemotherapy for Leptomeningeal Metastasis With Increased Intracranial Pressure.	Brain Tumor Res Treat	2022
33479772	Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma.	Brain	2021
33913266	The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1.	Brain Tumor Res Treat	2021
33913265	The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1.	Brain Tumor Res Treat	2021
34940608	Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic Profiles.	Metabolites	2021
34819930	Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13RÎ±2 and Suppress Malignant Glioma: A Preclinical Study.	Front Immunol	2021
34725983	Greetings From the New Editor-in-Chief.	Brain Tumor Res Treat	2021
34768379	Exploratory Profiling of Extracellular MicroRNAs in Cerebrospinal Fluid Comparing Leptomeningeal Metastasis with Other Central Nervous System Tumor Statuses.	J Clin Med	2021
34185980	Cerebrospinal Fluid Profiles and Their Changes after Intraventricular Chemotherapy as Prognostic or Predictive Markers for Patients with Leptomeningeal Carcinomatosis.	J Korean Neurosurg Soc	2021
34066445	Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases.	Cancers (Basel)	2021
33430103	Molecular Signature of Extracellular Vesicular Small Non-Coding RNAs Derived from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients: Functional Implication of miR-21 and Other Small RNAs in Cancer Malignancy.	Cancers (Basel)	2021
32532977	ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.	Nat Commun	2020
32849928	Comparative cerebrospinal fluid metabolites profiling in glioma patients to predict malignant transformation and leptomeningeal metastasis with a potential for preventive personalized medicine.	EPMA J	2020
32648383	Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis.	Brain Tumor Res Treat	2020
32987772	Nanoparticles in 472 Human Cerebrospinal Fluid: Changes in Extracellular Vesicle Concentration and miR-21 Expression as a Biomarker for Leptomeningeal Metastasis.	Cancers (Basel)	2020
32390350	A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma.	Brain Tumor Res Treat	2020
32390349	A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma.	Brain Tumor Res Treat	2020
32390348	A National Consensus Survey for Current Practice in Brain Tumor Management I: Antiepileptic Drug and Steroid Usage.	Brain Tumor Res Treat	2020
32502505	Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01).	Radiother Oncol	2020
32272509	Dexamethasone Interferes with Autophagy and Affects Cell Survival in Irradiated Malignant Glioma Cells.	J Korean Neurosurg Soc	2020
30293465	Local recurrence of brain metastasis reduced by intra-operative hyperthermia treatment.	Int J Hyperthermia	2019
31686446	Found at Old Age and Continuously Growing WHO Grade II Fourth Ventricle Ependymoma: A Case Report.	Brain Tumor Res Treat	2019
31686445	Discordance of Epidermal Growth Factor Receptor Mutation between Brain Metastasis and Primary Non-Small Cell Lung Cancer.	Brain Tumor Res Treat	2019
31686438	Efficacy of Slow Rate Ventriculolumbar Perfusion Chemotherapy for Leptomeningeal Carcinomatosis: Interim Result of a Phase II Study.	Brain Tumor Res Treat	2019
31062532	Choroid Plexus Carcinoma in Adults: Two Case Reports.	Brain Tumor Res Treat	2019
30917830	Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.	World J Surg Oncol	2019
31089925	Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.	J Neurooncol	2019
29260362	Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.	J Neurooncol	2018
30097825	Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.	J Neurooncol	2018
30196661	A Novel Implantable Cerebrospinal Fluid Reservoir : A Pilot Study.	J Korean Neurosurg Soc	2018
30247251	Treatment Results and Prognostic Factors of Brain Metastases From Ovarian Cancer: A Single Institutional Experience of 56 Patients.	Int J Gynecol Cancer	2018
30309209	Clinical outcome of proton therapy for patients with chordomas.	Radiat Oncol J	2018
29572674	Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.	J Neurooncol	2018
29717570	Extensive Pituitary Apoplexy after Chemotherapy in a Patient with Metastatic Breast Cancer.	Brain Tumor Res Treat	2018
27384161	Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.	Cancer Res Treat	2017
28485386	Monitoring rate and predictability of intraoperative monitoring in patients with intradural extramedullary and epidural metastatic spinal tumors.	Spinal Cord	2017
29254157	Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.	Oncotarget	2017
29198324	Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).	Crit Rev Oncol Hematol	2017
29188211	Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases.	Brain Tumor Res Treat	2017
28754668	Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPÎ² Signaling.	Cancer Res	2017
28676219	De novo cystic brain lesions mimicking neurocysticercosis in ALK-positive lung cancer.	Lung Cancer	2017
28881814	Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis.	Oncotarget	2017
27809457	Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients.	Cancer Res Treat	2017

1 - 50 of 102

Nancy Wang

Massachusetts General Hospital Cancer Center, Harvard Medical School

Career Start Year 2013

Number of shared co-authors 1

Priya Kumthekar

Northwestern University, Feinberg School of Medicine

Career Start Year 2013

Number of shared co-authors 2

Johannes Kerschbaumer

Medical University of Innsbruck

Career Start Year 2012

Number of shared co-authors 0

Noriyuki Kijima

Osaka University Graduate School of Medicine

Career Start Year 2011

Number of shared co-authors 1

Farshad Nassiri

Toronto Western Hospital, University Health Network, University of Toronto

Career Start Year 2010

Number of shared co-authors 3

Jenny Kan-Suen Pu

Queen Mary Hospital

Career Start Year 2009

Number of shared co-authors 0

Rohan Ramakrishna

Weill Cornell Medical College, New York Presbyterian Hospital

Career Start Year 2009

Number of shared co-authors 3

Yoshua Esquenazi

McGovern Medical School at UT Health Houston

Career Start Year 2007

Number of shared co-authors 1

Sherise D Ferguson

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 2

Gelareh Zadeh

University of Toronto

Career Start Year 2003

Number of shared co-authors 8

Matthias Preusser

Medical University of Vienna

Career Start Year 2003

Number of shared co-authors 1

Martin Glas

University Hospital Essen

Career Start Year 2002

Number of shared co-authors 2

Ichiyo Shibahara

Kitasato University School of Medicine

Career Start Year 2002

Number of shared co-authors 1

Mariza Daras

University of California san francisco

Career Start Year 2001

Number of shared co-authors 3

Andrew P Morokoff

Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital

Career Start Year 2001

Number of shared co-authors 0

Naoki Shinojima

Kumamoto University Hospital

Career Start Year 2000

Number of shared co-authors 7

Tracy T Batchelor

Brigham and Women's Hospital

Career Start Year 1996

Number of shared co-authors 2

Jung-Il Lee

Gangnam Severance Hospital

Career Start Year 1995

Number of shared co-authors 14

Ganesh Rao

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1994

Number of shared co-authors 10

Clark C Chen

University of Minnesota

Career Start Year 1994

Number of shared co-authors 4

Tom Mikkelsen

Ontario Brain Institute

Career Start Year 1990

Number of shared co-authors 8

Morris D Groves

The University of Texas MD Anderson Cancer Center

Career Start Year 1989

Number of shared co-authors 4

Motoo Nagane

Kyorin University Faculty of Medicine

Career Start Year 1988

Number of shared co-authors 1

Toshihiro Kumabe

Kitasato University School of Medicine

Career Start Year 1988

Number of shared co-authors 1

Camilo E Fadul

University of Virginia Health System

Career Start Year 1987

Number of shared co-authors 0

Michael A Vogelbaum

Moffit Cancer Center

Career Start Year 1986

Number of shared co-authors 4

Ryo Nishikawa

Saitama Medical University International Medical Center

Career Start Year 1986

Number of shared co-authors 1

Frederick F Lang

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1984

Number of shared co-authors 11

Raymond Sawaya

The University of Texas M.D. Anderson Cancer Center, American University of Beirut

Career Start Year 1979

Number of shared co-authors 12

David Schiff

University of Virginia School of Medicine

Career Start Year 1966

Number of shared co-authors 1

row(s) 1 - 30 of 30

Heon Yoo

Neuro-Oncology Clinic, National Cancer Center

Co-authored papers 56

Seung Hoon Lee

Korea University College of Medicine, Korea University Ansan Hospital

Co-authored papers 32

Jong Bae Park

Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University

Co-authored papers 17

Jong Heon Kim

Research Institute, National Cancer Center

Co-authored papers 17

Chul-Kee Park

College of Medicine, Seoul National University

Co-authored papers 11

Sun Ha Paek

Seoul National University College of Medicine

Co-authored papers 7

Youn-Jae Kim

Research Institute, National Cancer Center

Co-authored papers 7

Jeongwu Lee

Lerner Research Institute, Cleveland Clinic

Co-authored papers 5

Do-Hyun Nam

Samsung Medical Center, Sungkyunkwan University School

Co-authored papers 5

Sung Soo Kim

Institute of Vision Research, Yonsei University College of Medicine

Co-authored papers 4

Yong-Joon Chwae

Ajou University School of Medicine

Co-authored papers 4

Eun Young Kim

College of Korean Medicine, Kyung Hee University

Co-authored papers 4

Ho Jun Seol

Samsung Medical Center, Sungkyunkwan University School of Medicine

Co-authored papers 4

Jason K Sa

Korea University, College of Medicine

Co-authored papers 3

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 3

Takashi Shingu

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

Guk-Heui Jo

Myunggok Eye Research Institute, Konyang University College of Medicine

Co-authored papers 2

Nicholas P Farrell

Virginia Commonwealth University, United States of America Massey Cancer Center

Co-authored papers 2

Vaibhav Chumbalkar

Moffitt Cancer Center